Condition
Post-thoracotomy Pain
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 2 (1)
P 3 (1)
P 4 (2)
Trial Status
Completed3
Terminated1
Recruiting1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07275047Not ApplicableRecruitingPrimary
Analgesic Efficacy of SPSIP Block Versus Paravertebral Block Following Thoracotomy
NCT06685445Not ApplicableCompletedPrimary
Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy
NCT03618225Phase 4CompletedPrimary
Duloxetine Role in Reducing Opioid Consumption After Thoracotomy
NCT01582646Phase 2TerminatedPrimary
Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain
NCT00934193Phase 3WithdrawnPrimary
Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?
NCT01726205Phase 4CompletedPrimary
Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy
Showing all 6 trials